Linked Life Data

11517127

Source:http://linkedlifedata.com/resource/pubmed/id/11517127

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11517127rdf:typepubmed:Citationlld:pubmed
pubmed-article:11517127lifeskim:mentionsumls-concept:C0008059lld:lifeskim
pubmed-article:11517127lifeskim:mentionsumls-concept:C0005794lld:lifeskim
pubmed-article:11517127lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:11517127lifeskim:mentionsumls-concept:C0014822lld:lifeskim
pubmed-article:11517127lifeskim:mentionsumls-concept:C0189745lld:lifeskim
pubmed-article:11517127lifeskim:mentionsumls-concept:C0439859lld:lifeskim
pubmed-article:11517127lifeskim:mentionsumls-concept:C0445204lld:lifeskim
pubmed-article:11517127pubmed:issue3lld:pubmed
pubmed-article:11517127pubmed:dateCreated2001-8-22lld:pubmed
pubmed-article:11517127pubmed:abstractTextWe assessed the feasibility and efficacy of subcutaneous erythropoietin alpha (EPO) therapy and preoperative autologous blood donation (ABD) in children undergoing open heart surgery. Thirty-nine children were treated consecutively with EPO (100 U x kg(-1) s.c. three times a week in the 3 weeks preceding the operation and i.v. on the day of surgery) and two ABDs were made (Group 1). As controls to compare transfusion requirements, 39 consecutive age-matched patients who had undergone open heart surgery during the two preceding years were selected (Group 2). In a mean time of 20 (SD 5) days, 96% of scheduled ABDs were performed and only three mild vasovagal reactions were observed. The mean volume of autologous red blood cells (RBC) collected was 6 (1) ml x kg(-1) and the mean volume of autologous RBC produced as a result of EPO therapy before surgery was 7 (3) ml x kg(-1), corresponding to a 28 (11)% increase in circulating RBC volume. The mean volume of autologous RBC collected was not different from that produced [6 (1) vs 7 (3) ml x kg(-1), P=0.4]. Allogenic blood was administered to three out of 39 children in Group 1 (7.7%) and to 24 out of 39 (61.5%) in Group 2. Treatment with subcutaneous EPO increases the amount of autologous blood that can be collected and minimizes allogenic blood exposure in children undergoing open heart surgery.lld:pubmed
pubmed-article:11517127pubmed:languageenglld:pubmed
pubmed-article:11517127pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11517127pubmed:citationSubsetIMlld:pubmed
pubmed-article:11517127pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11517127pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11517127pubmed:statusMEDLINElld:pubmed
pubmed-article:11517127pubmed:monthSeplld:pubmed
pubmed-article:11517127pubmed:issn0007-0912lld:pubmed
pubmed-article:11517127pubmed:authorpubmed-author:CrupiGGlld:pubmed
pubmed-article:11517127pubmed:authorpubmed-author:ShahV GVGlld:pubmed
pubmed-article:11517127pubmed:authorpubmed-author:FerreJJlld:pubmed
pubmed-article:11517127pubmed:authorpubmed-author:SonzogniVVlld:pubmed
pubmed-article:11517127pubmed:authorpubmed-author:BellavitaPPlld:pubmed
pubmed-article:11517127pubmed:authorpubmed-author:FilisettiPPlld:pubmed
pubmed-article:11517127pubmed:authorpubmed-author:AnnechinoFFlld:pubmed
pubmed-article:11517127pubmed:issnTypePrintlld:pubmed
pubmed-article:11517127pubmed:volume87lld:pubmed
pubmed-article:11517127pubmed:ownerNLMlld:pubmed
pubmed-article:11517127pubmed:authorsCompleteYlld:pubmed
pubmed-article:11517127pubmed:pagination429-34lld:pubmed
pubmed-article:11517127pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:11517127pubmed:meshHeadingpubmed-meshheading:11517127...lld:pubmed
pubmed-article:11517127pubmed:meshHeadingpubmed-meshheading:11517127...lld:pubmed
pubmed-article:11517127pubmed:meshHeadingpubmed-meshheading:11517127...lld:pubmed
pubmed-article:11517127pubmed:meshHeadingpubmed-meshheading:11517127...lld:pubmed
pubmed-article:11517127pubmed:meshHeadingpubmed-meshheading:11517127...lld:pubmed
pubmed-article:11517127pubmed:meshHeadingpubmed-meshheading:11517127...lld:pubmed
pubmed-article:11517127pubmed:meshHeadingpubmed-meshheading:11517127...lld:pubmed
pubmed-article:11517127pubmed:meshHeadingpubmed-meshheading:11517127...lld:pubmed
pubmed-article:11517127pubmed:meshHeadingpubmed-meshheading:11517127...lld:pubmed
pubmed-article:11517127pubmed:meshHeadingpubmed-meshheading:11517127...lld:pubmed
pubmed-article:11517127pubmed:meshHeadingpubmed-meshheading:11517127...lld:pubmed
pubmed-article:11517127pubmed:meshHeadingpubmed-meshheading:11517127...lld:pubmed
pubmed-article:11517127pubmed:meshHeadingpubmed-meshheading:11517127...lld:pubmed
pubmed-article:11517127pubmed:meshHeadingpubmed-meshheading:11517127...lld:pubmed
pubmed-article:11517127pubmed:meshHeadingpubmed-meshheading:11517127...lld:pubmed
pubmed-article:11517127pubmed:meshHeadingpubmed-meshheading:11517127...lld:pubmed
pubmed-article:11517127pubmed:meshHeadingpubmed-meshheading:11517127...lld:pubmed
pubmed-article:11517127pubmed:year2001lld:pubmed
pubmed-article:11517127pubmed:articleTitleErythropoietin therapy and preoperative autologous blood donation in children undergoing open heart surgery.lld:pubmed
pubmed-article:11517127pubmed:affiliationDepartment of Anesthesiology, Ospedali Riuniti di Bergamo, Bergamo, Italy.lld:pubmed
pubmed-article:11517127pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11517127pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:11517127pubmed:publicationTypeControlled Clinical Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11517127lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11517127lld:pubmed